India, July 6 -- Aethlon Medical, Inc. (AEMD) announced it has priced a $4.0 million follow-on public offering, structured at-the-market under Nasdaq rules.
The offering consists of 5,633,009 shares of its common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to an equal number of shares, at a combined public offering price of $0.7101 per share (or pre-funded warrant) and warrant.
The warrants carry an exercise price of $0.7101 per share, become exercisable upon stockholder approval, and will expire five years thereafter.
The securities are immediately separable and will be issued separately. Closing is expected on or about July 7, 2026, subject to customary conditions. Maxim Group LLC is acting a...